PCM
OCDX

Pentwater Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Pentwater Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-55,000
Closed -$1.06M – 404
2021
Q1 		$1.06M Buy
+55,000
New +$969K 0.01% 214

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pentwater Capital Management's OCDX Position: Q2 2021 in Review

Pentwater Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2021, closing a stake of 55,000 shares — an estimated $1.06M sold.

Pentwater Capital Management first reported a position in OCDX in Q1 2021 and held it in 1 quarter. The position peaked at $1.06M in Q1 2021. 106 funds tracked by Wall St. Rank hold OCDX as of Q2 2021.

  • Pentwater Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Pentwater Capital Management sold 55,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2021, an estimated $1.06M.
  • Pentwater Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 1 quarter.
  • Pentwater Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.06M in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2021.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.